During the past decade, Diakonie-Klinikum Schwäbisch Hall gGmbH conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diakonie-Klinikum Schwäbisch Hall gGmbH" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials, followed by "Technische Universität Dresden" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored, "AIO-Studien-gGmbH" with 1 trials sponsored and "Abbott Medical Devices" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diakonie-Klinikum Schwäbisch Hall gGmbH" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Aesculap AG" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Diakonie-Klinikum Schwäbisch Hall gGmbH" are "Lymphoma" (3 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Acute Myeloid Leukemia" (1 trials), "Brain Ischemia With Non-valvular Atrial Fibrillation" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Diakonie-Klinikum Schwäbisch Hall gGmbH" in a lesser frequency.

Most popular intervention types in "Diakonie-Klinikum Schwäbisch Hall gGmbH" are "Drug" (11 trials), "Biological" (5 trials), "Procedure" (3 trials), "Radiation" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials), "prednisone" (3 trials), "radiation therapy" (3 trials) and "vincristine sulfate" (3 trials). Other intervention names were less common.

The vast majority of trials in "Diakonie-Klinikum Schwäbisch Hall gGmbH" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Diakonie-Klinikum Schwäbisch Hall gGmbH". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Diakonie-Klinikum Schwäbisch Hall gGmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Diakonie-Klinikum Schwäbisch Hall gGmbH, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Diakonie-Klinikum Schwäbisch Hall gGmbH has several departments that took part in Clinical trials: "Diakonie-Klinikum Schwäbisch Hall gGmbH, Innere Medizin III" - 2 trials